Gibson, Dunn & Crutcher LLP advised Biosynth in the transaction. Biosynth, a portfolio company of KKR, announced its acquisition of celares GmbH. The terms and conditions of the...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised Biosynth Carbosynth, a portfolio company of the KKR Health Care Growth fund, in its acquisition of Pepscan Therapeutics and Pepscan...
You must be a Standard 1 Year member to access this content.
Arthur Cox partnered with Gibson, Dunn & Crutcher LLP in advising Biosynth Carbosynth. Biosynth Carbosynth, a supplier of critical materials to the life science industry, on...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP and BDGS Associés advised KKR on the deal. Ornikar, a specialist in driver training and road awareness since 2013, announced a €100 million...
You must be a Standard 1 Year member to access this content.
